Can-C™ is a product that has been proven effective in reversing and controlling the age-related disorder, senile cataract. Developed and patented by Innovative Vision Products, Can-C contains the active ingredient, special form of N-acetylcarnosine or NAC, a dipeptide that can be found naturally in the human body. Its parent compound, carnosine is a natural component in food and human cells such as the heart, skeletal muscles, and the brain.
N-Acetylcarnosine is an important molecule that plays an important role in the prevention of age-related diseases. It acts as an antioxidant as well as an inhibitor of the age related glycation process.
Although carnosine is naturally present in the body, its amount is affected by the age of the person. As the human body ages, the level of carnosine in the body decreases. When this happens, age-related disorders like senile cataracts begin to present.
Cataract is a visual impairment disease in which the patient complains of blurriness, glare sensitivity and diminished visual ocuity, which can ultimately lead to blindness. The problem happens with the aged eye lens. The clear lens of the eye develops an opacity which progressively hinders vision. Upon doctor's advice, the usual treatment is eye surgery to remove the cloudy lens and replacing it with an artificial one.
However, as with any surgery, there are risks to the patient which can vary from bleeding to having post surgery eye infection. But not all types of cataracts need surgery now that there is a non invasive option for dealing with cataract.
With the breakthrough of effectively re-introducing carnosine into the cells of the eye topically, thousands are now choosing a more natural approach to treating cataract..
Can-C™ which is available as an eye drop provides the most direct delivery route of carnosine to the aqueous humor of the eye. The ‘N-acetyl' part of the molecule is what makes carnosine soluble in lipids. This means the ‘N-acetyl' component helps in the absorption of the molecule into the lipid membranes of the retinal, corneal and lens cells. Once N-acetylcarnosine is delivered into the cell, it then releases the basic component, carnosine where it then exerts its beneficial antioxidant effects, with no side effects.
The use of Can-C™ in treating cataracts has been studied over the last twelve years now by a leading group of Russian medical researchers. Over that time frame this amazing antioxidant eye drop has generated thousands of reports of safe and effective cataract reversal both in humans and animals.
The human trial results revealed that those affected for less than 7 years had the fastest and greatest improvement, those with cataracts for 7-15 years still had good results and those that had the disease for over 15 years had the least beneficial results but still obtained measurable visual improvement.
The recommended dose for treatment is 2 drops, twice a day applied to the affected eye with visual ocuity improvements in just 90 days time. For optimal results, it's recommended that application is continue for a period 6-12 months. Then for preventing the recurrence of cataract, a dosage of 1 drop a day on the eye is recommend as an on-going regimen.
This article is free to republish provided the authors resource box remains intact.
Can C Eye Drops
Over the last ten years, Dr. Mark Babizhayev and his team of Russian medical researchers have continued to observe the ongoing beneficial effects of this breakthrough cataract eye drop. In clinical trials conducted, it showed that patients instilled with two drops of the 1% N-acetylcarnosine (Can-C?) eye drops twice daily for a period of 6 months showed vast improvement in their pre-existing eye conditions. The effective rate was a reported 100%. These results led to the patent and manufacture of the product providing a long awaited, safe and effective alternative to cataract surgery.
How do Can-C? eye drops actually reverse cataracts? This eye drop with a proprietary form of N-acetylcarnosine acts as a carrier for the di-peptide, carnosine. Carnosine which is naturally present throughout the human body decreases in level as each person advances in age which contibutes to the onset of age-related problems such as cataract. Carnosine is both a known antioxidant and glycation inhibitor. When it comes to ocular disease such as cataract, eye drops are the most direct delivery route to the source of the problem, which is the ocular lens. In the form of N-acetyl-carnosine, this normally insoluble lipid, carnosine, becomes lipid soluble thus gaining entrance into the lipid membrane of both the corneal and lens cells. This bioavailability of N-acetylcarnosine at the cellular level and its ultimate release of the carnosine molecule is what results in the reported beneficial effects on the eye.
What is the difference between N-acetylcarnosine and L-carnosine? Firstly, studies show that only N-acetylcarnosine is clinically proven to be suitable for eye use. Unfortunately L-carnosine when administered topically on its own is destroyed by the enzyme, carnosinase, a dipeptidase present in blood plasma. Due to this, simple L-carnosine eye drops are not suitable for topical application to the eye.
Can-C? eye drops with N-acetylcarnosine are not only effective in the treatment of cataract but have been shown to be beneficial for other eye problems such as open-angle primary glaucoma, computer vision syndrome, dry eye syndrome, retinal disease, complications of diabetes mellitus and other systemic diseases, etc. Can-C? has been reported to have virtually no negative side effects however when using other eye medications it is always recommended to consult first with your eye care specialist.
With the release of the Can-C? product into the market supported by the clinical study results, various medical and pharmaceutical companies quickly released copycat cataract eye drop solutions containing N-acetylcarnosine. Dr. Mark Babizhayev the senior research investigator with Innovative Vision Products cautions consumers to be wary of these random formulations. The successful clinical results were dependent upon a highly specific purity factor of the raw material itself or rather, the precise content of the transition metal ion traces. This patent protected refinement of the Can-C? N-acetylcarnosine raw material, with a Japanese chemical company, is what ultimately resulted in the anti-cataract successes achieved and long term safety. It is only this proprietary form of N-acetylcarnosine raw material that will ever be used in Can-C? and this purity factor remains proprietary to Innovative Vision Products. Fortunately there is a simple way for consumers to verify if they have purchased the clinically proven formula patented by Innovative Vision Products as the following statement is printed on each and every box, "Approved by Innovative Vision Products.? To obtain the desired long-term efficacy and safety of this eye drops be sure to purchase Can-C? and be sure to look for this statement on the side panel of the box "Approved by Innovative Vision Products (IVP)?.
If you would like to read more about Dr. Mark Babizhayev, his research, testimonials or are a Physician, Veterinarian or Alternative Health Care Practitioner wishing to find out more then please visit the N-Acetylcarnosine (Can-C?) Cataract Eye Drop website at http://wisechoicemedicine.net where there is detailed information and full scientific explanations available.
Leslie Burke has sinced written about articles on various topics from Medicine, Medical Condition. Leslie Burke has a vast knowledge and experience with Can-C™ and on. Leslie Burke's top article generates over 2900 views. to your Favourites.
Assisted Living In Ri ? Personal crime rates are at .8 while property crimes are at 5
